Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian Cancer
J Clin Oncol
.
2016 Dec 20;34(36):4312-4314.
doi: 10.1200/JCO.2016.69.7169.
Epub 2016 Oct 23.
Authors
Alison M Schram
1
,
Alexia Iasonos
1
,
David M Hyman
1
Affiliation
1
Alison M. Schram, Alexia Iasonos, and David M. Hyman, Memorial Sloan Kettering Cancer Center, New York, NY.
PMID:
27998226
PMCID:
PMC5455312
DOI:
10.1200/JCO.2016.69.7169
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Carboplatin
Drug Resistance, Neoplasm
ErbB Receptors*
Female
Humans
Ovarian Neoplasms
Platinum*
Substances
Platinum
Carboplatin
ErbB Receptors
Grants and funding
P30 CA008748/CA/NCI NIH HHS/United States
R25 CA020449/CA/NCI NIH HHS/United States
T32 CA009207/CA/NCI NIH HHS/United States